The 5% Trap: Why Hospital Women's Health Expansions Are Failing to Drive Revenue

The 5% Trap: Why Hospital Women's Health Expansions Are Failing to Drive Revenue
By: Women's HealthX Editorial

51% of provider organizations admit their specialized maternal and gynecological expansions contribute less than 5% to downstream revenue.

Boston MA -- October 6: Health systems are successfully building the front door to women's healthcare, but they are completely failing to capture the lifetime value of those patients.

The Women's Health Infrastructure Report 2026 reveals that despite growing investment and strategic focus, many hospitals remain in the early stages of realizing the true commercial potential of female-focused care.

51%
of health systems report specialized women's health expansions drive less than 5% of downstream revenue.

While access expansion and service line growth are universally ranked as key priorities, a glaring growth illusion persists[cite: 13]. By treating pregnancy as a discrete, isolated event rather than a window into a woman's lifelong health trajectory, systems are losing patients to fragmented outpatient providers the moment the pregnancy episode ends.

Percentage of Downstream Revenue Driven by Maternal & Gynecological Expansions
Less than 5%
51%
16-20%
18%
More than 20%
14%
6-10%
13%
11-15%
4%
Carlos Roberts
"Many women receive excellent prenatal care, but they fall off a 'postpartum cliff' after delivery... Because the transition between obstetrics and primary care is so poorly coordinated, there is often no clearly accountable provider once the pregnancy ends. Health systems must organize around coordinated care beyond the pregnancy episode to truly improve long-term health."
Carlos Roberts
Vice President/Chief Medical Officer, Women's & Children's Serviceline, Wellspan Medical Group
What This Means
Health systems must bridge the transition from obstetrics to primary care to prevent patients from abandoning the network. Sustainable growth requires treating maternal care as a longitudinal acquisition strategy rather than a discrete clinical event.

This finding represents just one of dozens of insights uncovered through the Women's Health Infrastructure Report 2026, a cross-sector study bringing together perspectives from health plans, providers, employers, clinicians, life sciences organisations and innovators.

The full report features detailed findings, expert commentary, benchmark data and practical implications for healthcare leaders looking to understand where women's health is heading next.

Lead Research Partner
Foraviset

Women’s HealthX 2026 | From Rhetoric to Results

Encore Boston Harbor | December 3-4 2026

Bypass abstract market rhetoric to evaluate real-world health economics, regulatory compliance mandates, and care delivery systems. Join the region's foremost health plan medical directors, hospital COOs, biopharma innovators, and enterprise benefits buyers anchoring our 2026 tracks.